Trade NNNN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Anbio Biotechnology Class A (NNNN) is trading at US$5.25, down 6.25% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$298.9M. Over the past 52 weeks, NNNN has traded between US$5.13 and US$51.33. On Syfe you can trade NNNN with $0 commission and add it to your watchlist.
| Previous close | US$5.60 |
|---|---|
| Market cap | US$298.9M |
| 52-week range | US$5.13 – US$51.33 |
| Volume | 289.95K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Anbio Biotechnology Class A
Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products. The company was founded on July 27, 2021 and is headquartered in Frankfurt, Germany.
Year: 2025
Anbio Biotechnology Files Mixed Shelf Registration
Jul 9, 9:52 PM · MT Newswires
Anbio Biotechnology Class A (NNNN) stock is trading at US$5.25, -6.25% from the previous close of US$5.60.
The market cap for Anbio Biotechnology Class A (NNNN) stock is approximately US$298.9M.
The 52-week high for Anbio Biotechnology Class A (NNNN) stock is US$51.33.
The 52-week low for Anbio Biotechnology Class A (NNNN) stock is US$5.13.
Anbio Biotechnology Class A (NNNN) does not currently pay a dividend.
Stay on top of NNNN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
